The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity
Published version of a preprint
Abstract
Hyperactivation of the mammalian target of rapamycin (mTOR) pathway can cause malformation of cortical development (MCD) with associated epilepsy and intellectual disability (ID) through a yet unknown mechanism. Here, we made use of the recently identified dominant-active mutation in Ras Homolog Enriched in Brain 1 ( RHEB ), RHEBp.P37L, to gain insight in the mechanism underlying the epilepsy caused by hyperactivation of the mTOR pathway. Focal expression of RHEBp.P37L in mouse somatosensory cortex (SScx) results in an MCD-like phenotype, with increased mTOR signaling, ectopic localization of neurons, and reliable generalized seizures. We show that in this model, the mTOR-dependent seizures are caused by enhanced axonal connectivity, causing hyperexcitability of distally connected neurons. Indeed, blocking axonal vesicle release from the RHEBp.P37L neurons alone completely stopped the seizures and normalized the hyperexcitability of the distally connected neurons. These results provide new evidence of the extent of anatomical and physiological abnormalities caused by mTOR hyperactivity, beyond local malformations, which can lead to generalized epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of mTOR is known to promote dendritic morphological complexity and axonal regeneration in RGCs, while also functioning as a negative regulator of autophagy through the mTORC1 complex [49–53].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections
Petreanu, L., Huber, D., Sobczyk, A., & Svoboda, K. (2007) · Nature Neuroscience · doi:10.1038/nn1891 · Cited by 930 · cited 6×
“They also send collaterals to L2/3 and, more strongly, L5 pyramidal neurons within the same column ipsilaterally, participating in local circuitry [32,33].”
BackgroundMethodInfluentialBhaskar, P. T., & Hay, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.020 · Cited by 798
Extracellular vesicles round off communication in the nervous system
Budnik, V., Ruiz-Cañada, C., & Wendler, F. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.29 · Cited by 712
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
van Slegtenhorst, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1053 · Cited by 565
BDNF and epilepsy: too much of a good thing?
Binder, D. K., Croll, S. D., Gall, C. M., & Scharfman, H. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01682-9 · Cited by 454
Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38
Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., & Jiang, Y. (2007) · Science · doi:10.1126/science.1147379 · Cited by 382
Development, specification, and diversity of callosal projection neurons
Fame, R. M., MacDonald, J. L., & Macklis, J. D. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.002 · Cited by 381
mTOR: A pathogenic signaling pathway in developmental brain malformations
Crino, P. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.008 · Cited by 266
Ribierre, T., Deleuze, C., Bacq, A., Baldassari, S., Marsan, E., Chipaux, M., Muraca, G., Roussel, D., Navarro, V., Leguern, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99384 · Cited by 241
Blümcke, I., Vinters, H. V., Armstrong, D., Aronica, E., Thom, M., & Spreafico, R. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0261 · Cited by 145
Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
Krueger, D. A., Sadhwani, A., Byars, A. W., de Vries, P. J., Franz, D. N., Whittemore, V. H., Filip‐Dhima, R., Murray, D., Kapur, K., & Sahin, M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.494 · Cited by 133
Lineage-specific laminar organization of cortical GABAergic interneurons
Ciceri, G., Dehorter, N., Sols, I., Huang, Z. J., Maravall, M., & Marín, O. (2013) · Nature Neuroscience · doi:10.1038/nn.3485 · Cited by 124
Park, S. M., Lim, J. S., Ramakrishina, S., Kim, S. H., Kim, W. K., Lee, J., Kang, H.-C., Reiter, J. F., Kim, D. S., Kim, H. (., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.039 · Cited by 114
Reijnders, M. R. F., Kousi, M., van Woerden, G. M., Klein, M., Bralten, J., Mancini, G. M. S., van Essen, T., Proietti-Onori, M., Smeets, E. E. J., van Gastel, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00933-6 · Cited by 76 · cited 7×
“S68P)) in patients with ID, epilepsy, and megalencephaly [23], providing for the first time a clinically relevant link between RHEB and MCD.”
BackgroundMethodResultInfluentialRheb G-Proteins and the Activation of mTORC1
(2010) · The Enzymes · doi:10.1016/s1874-6047(10)27003-8 · Cited by 41 · cited 4×
“Abbreviations: ABC, avidin-biotinperoxidase complex; ACSF, artificial cerebrospinal fluid; AED, antiepileptic drug; BDNF, brain-derived neurotrophic factor; DAPI, 40,6-diamidino-2phenylindole; DIV1, 1 day in vitro; DMEM, Dulbecco’s modified Eagle medium; EEG, electroencephalography; EPSC, excitatory postsynaptic poten…”
BackgroundInfluential
Research works printed but not linked: 60
- AJ Barkovich, 2012, A developmental and genetic classification for malformations of cortical development: Update 2012, Brain. Narnia, 1348, 10.1093/brain/aws019 · DOI · Paper page
- G Juric-Sekhar, 2019, Malformations of Cerebral Cortex Development: Molecules and Mechanisms, Annu Rev Pathol Mech Dis, 14, 293, 10.1146/annurev-pathmechdis-012418-012927 · DOI
- RJ Leventer, 2008, Malformations of cortical development and epilepsy, Dialogues in Clinical Neuroscience. Les Laboratoires Servier, 47, 10.31887/DCNS.2008.10.1/rjleventer · DOI · Paper page
- A. Represa, 2019, Why Malformations of Cortical Development Cause Epilepsy, Front Neurosci, 13, 250, 10.3389/fnins.2019.00250 · DOI
- RJ Leventer, 1999, Clinical and imaging features of cortical malformations in childhood, Neurology, 53, 715, 10.1212/WNL.53.4.715 · DOI · Paper page
- M Laplante, 2012, mTOR Signaling, Cold Spring Harb Perspect Biol, 4, a011593, 10.1101/cshperspect.a011593 · DOI · Paper page
- RA Saxton, 2017, mTOR Signaling in Growth, Metabolism and Disease, Cell, 960, 10.1016/j.cell.2017.02.004 · DOI · Paper page
- N Parmar, 2010, The Enzymes, 39
- Y Li, 2004, Guan. Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity, Mol Cell Biol, 24, 7965, 10.1128/MCB.24.18.7965-7975.2004 · DOI · Paper page
- BD Manning, 2003, Trends in Biochemical Sciences, 573
- DM Sabatini, 2017, Twenty-five years of mTOR: Uncovering the link from nutrients to growth, Proceedings of the National Academy of Sciences of the United States of America. National Academy of Sciences, 11818, 10.1073/pnas.1716173114 · DOI · Paper page
- SMI Goorden, 2015, Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments, Hum Mol Genet, 24, 3390, 10.1093/hmg/ddv087 · DOI
- JJ Moffat, 2015, Genes and brain malformations associated with abnormal neuron positioning, Mol Brain, 8, 1, 10.1186/s13041-015-0164-4 · DOI
- N Chevassus-au-Louis, 1999, Ben-Ari. Cortical Malformations and Epilepsy: New Insights from Animal Models, Epilepsia, 40, 811, 10.1111/j.1528-1157.1999.tb00786.x · DOI
- M Wong, 2016, Genetic animal models of malformations of cortical development and epilepsy, J Neurosci Methods NIH Public Access, 73, 10.1016/j.jneumeth.2015.04.007 · DOI
- S Hanai, 2017, Pathologic Active mTOR Mutation in Brain Malformation with Intractable Epilepsy Leads to Cell-Autonomous Migration Delay, Am J Pathol, 187, 1177, 10.1016/j.ajpath.2017.01.015 · DOI
- LS Hsieh, 2016, Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement, Nat Commun, 7, 11753, 10.1038/ncomms11753 · DOI
- L Yan, 2006, Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase, J Biol Chem, 281, 19793, 10.1074/jbc.C600028200 · DOI
- LH Nguyen, 2019, mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia, J Neurosci, 39, 2762, 10.1523/JNEUROSCI.2260-18.2019 · DOI
- L Chauvière, 2009, Early deficits in spatial memory and theta rhythm in experimental temporal lobe epilepsy, J Neurosci, 29, 5402, 10.1523/JNEUROSCI.4699-08.2009 · DOI · Paper page
- DZ Milikovsky, 2017, Electrocorticographic dynamics as a novel biomarker in five models of epileptogenesis, J Neurosci, 37, 4450, 10.1523/JNEUROSCI.2446-16.2017 · DOI
- E Abs, 2013, TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice, Ann Neurol, 74, 569, 10.1002/ana.23943 · DOI
- Y-J Choi, 2008, Tuberous sclerosis complex proteins control axon formation, Genes Dev, 22, 2485, 10.1101/gad.1685008 · DOI · Paper page
- X Gong, 2015, Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo, Hum Mol Genet, 24, 5746, 10.1093/hmg/ddv295 · DOI
- D Nie, 2010, Tsc2-Rheb signaling regulates EphA-mediated axon guidance, Nat Neurosci, 13, 163, 10.1038/nn.2477 · DOI · Paper page
- LR Fenlon, 2017, The anatomy, organisation and development of contralateral callosal projections of the mouse somatosensory cortex, Brain Neurosci Adv, 1, 239821281769488, 10.1177/2398212817694888 · DOI
- GG Schiavo, 1992, Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin, Nature, 359, 832, 10.1038/359832a0 · DOI · Paper page
- HY Gaisano, 1994, Tetanus toxin light chain cleaves a vesicle-associated membrane protein (VAMP) isoform 2 in rat pancreatic zymogen granules and inhibits enzyme secretion, J Biol Chem, 269, 17062, 10.1016/S0021-9258(17)32520-6 · DOI
- M Shimojo, 2015, SNAREs Controlling Vesicular Release of BDNF and Development of Callosal Axons, Cell Rep, 11, 1054, 10.1016/j.celrep.2015.04.032 · DOI
- C-L Wang, 2007, Activity-dependent development of callosal projections in the somatosensory cortex, J Neurosci, 27, 11334, 10.1523/JNEUROSCI.3380-07.2007 · DOI · Paper page
- JS Lim, 2015, Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy, Nat Med, 21, 395, 10.1038/nm.3824 · DOI · Paper page
- ST Baek, 2015, An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development, Nat Med, 21, 1445, 10.1038/nm.3982 · DOI
- AM D’Gama, 2017, Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias, Cell Rep, 21, 3754, 10.1016/j.celrep.2017.11.106 · DOI · Paper page
- S Hu, 2018, Somatic Depdc5 deletion recapitulates electroclinical features of human focal cortical dysplasia type IIA, Ann Neurol, 84, 140, 10.1002/ana.25272 · DOI
- IE Overwater, 2019, Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives, Ther Clin Risk Manag, 15, 951, 10.2147/TCRM.S145630 · DOI
- IE Overwater, 2016, Sirolimus for epilepsy in children with tuberous sclerosis complex, Neurology, 87, 1011, 10.1212/WNL.0000000000003077 · DOI
- IE Overwater, 2019, A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex, Neurology, 93, E200, 10.1212/WNL.0000000000007749 · DOI
- PT Tsai, 2013, Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice, Behav Genet, 43, 51, 10.1007/s10519-012-9571-9 · DOI
- SW Way, 2012, The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex, Hum Mol Genet, 21, 3226, 10.1093/hmg/dds156 · DOI
- F Chassoux, 2008, Intralesional recordings and epileptogenic zone in focal polymicrogyria, Epilepsia, 49, 51, 10.1111/j.1528-1167.2007.01267.x · doi:10.1111/j.1528-1167.2007.01267.x
- P Major, 2009, Are cortical tubers epileptogenic? Evidence from electrocorticography, Epilepsia, 50, 147, 10.1111/j.1528-1167.2008.01814.x · DOI · Paper page
- C Cepeda, 2005, Epilepsia, 82
- C Cepeda, 2012, Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex, Neurobiol Dis, 45, 310, 10.1016/j.nbd.2011.08.015 · DOI
- C Cepeda, 2003, Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia, J Neurosci Res, 72, 472, 10.1002/jnr.10604 · DOI · Paper page
- S Abdijadid, 2015, CNS Neuroscience and Therapeutics, 92
- GW Mathern, 2007, A hypothesis regarding the pathogenesis and epileptogenesis of pediatric cortical dysplasia and hemimegalencephaly based on MRI cerebral volumes and NeuN cortical cell densities, Epilepsia, 74, 10.1111/j.1528-1167.2007.01292.x · doi:10.1111/j.1528-1167.2007.01292.x
- B Patel, 2015, Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex, Oncogene, 1
- CM Fader, 2009, TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways, Biochim Biophys Acta, Mol Cell Res., 1793, 1901, 10.1016/j.bbamcr.2009.09.011 · DOI · Paper page
- DK Binder, 2001, Trends in Neurosciences, 47
- T Matsuda, 2007, Controlled expression of transgenes introduced by in vivo electroporation, Proc Natl Acad Sci U S A, 104, 1027, 10.1073/pnas.0610155104 · DOI · Paper page
- MJ Groenewoud, 2013, Mammalian target of rapamycin complex I (mTORC1) activity in ras homologue enriched in brain (Rheb)-deficient mouse embryonic fibroblasts, PLoS ONE, 8, e81649, 10.1371/journal.pone.0081649 · DOI
- G Banker, 1988, Developments in neuronal cell culture, Nature Nature Publishing Group, 185
- LG Dufner Almeida, 2019, Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings, Hum Mutat
- CR Yu, 2004, Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map, Neuron, 42, 553, 10.1016/S0896-6273(04)00224-7 · DOI · Paper page
- T Saito, 2001, Efficient gene transfer into the embryonic mouse brain using in vivo electroporation, Dev Biol, 240, 237, 10.1006/dbio.2001.0439 · DOI · Paper page
- LMC Koene, 2019, Effects of antiepileptic drugs in a new TSC/mTOR-dependent epilepsy mouse model, Ann Clin Transl Neurol, 6, 1273, 10.1002/acn3.50829 · DOI
- MJ Kool, 2019, CAMK2-dependent signaling in neurons is essential for survival, J Neurosci, 1341
- N Kane, 2017, A revised glossary of terms most commonly used by clinical electroencephalographers and updated proposal for the report format of the EEG findings. Revision 2017, Clin Neurophysiol Pract, 2, 170, 10.1016/j.cnp.2017.07.002 · DOI · Paper page
- JT Ting, 2014, Acute brain slice methods for adult and aging animals: Application of targeted patch clamp analysis and optogenetics, Methods Mol Biol, 1183, 221, 10.1007/978-1-4939-1096-0_14 · DOI · Paper page
- SK Schmitz, 2011, Automated analysis of neuronal morphology, synapse number and synaptic recruitment, J Neurosci Methods, 195, 185, 10.1016/j.jneumeth.2010.12.011 · DOI · Paper page
Cited by
Nguyen, L. H., Xu, Y., Nair, M., & Bordey, A. (2024) · eLife · doi:10.7554/elife.91010 · Cited by 37
Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01872-2 · Cited by 19
Metadata
- Authors
- Proietti Onori, M., Koene, L. M. C., Schäfer, C. B., Nellist, M., de Brito van Velze, M., Gao, Z., Elgersma, Y., & van Woerden, G. M.
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-05-26
- Volume
- 19
- Issue
- 5
- Pages
- e3001279
- ISSN
- 1545-7885
- Cited by
- 59
- References
- 15
- Language
- en
- Update notices
- new_version (2021-06-08)
- Funders
- Dutch TSC Foundation
- Epilepsiefonds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.